Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05941429Phase 1Active, not recruiting
Phase 1, randomised trial of nanosilver fluoride in dental caries (2 arms), sponsored by Cairo University. Primary endpoint: Caries lesion activity and severity assessment using Nyvad criteria at 6 months. Started Feb 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05941429.